APO Research
Talk to an analyst

APO RESEARCH · REPORT

Functional Genomics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Functional Genomics Market Outlook and Growth Opportunities 2026

4 July 2026192 pages

Choose your research edition.

Industry ResearchFunctional Genomics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Functional Genomics Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Functional Genomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Functional Genomics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Functional Genomics Market Analysis and Forecast 2026-2032177 pages · $4,950 USD

Market perspective

The global Functional Genomics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Functional Genomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Functional Genomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Functional Genomics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Functional Genomics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Functional Genomics market include Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA and MRM Proteomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Functional Genomics market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Functional Genomics and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Functional Genomics revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Functional Genomics market.

Functional Genomics Segment by Company

Agilent Technologies, Inc.

Becton, Dickinson and Company (BD)

Bio-Rad Laboratories, Inc.

(Integrated DNA Technologies, Inc.)

Exact Sciences Corporation

Hoffmann-La Roche Ltd

Illumina, Inc.

Merck KGaA

MRM Proteomics

Pacific Biosciences of California, Inc.

Promega Corporation

QIAGEN

Thermo Fisher Scientific Inc.

Functional Genomics Segment by Type

Kits & Assays

Instruments

Assays

Functional Genomics Segment by Application

Transcriptomics

Epigenomics

Proteomics

Metabolomics

Functional Genomics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Functional Genomics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Functional Genomics key companies, revenue, market share, and recent developments.

3. To split the Functional Genomics breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Functional Genomics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Functional Genomics significant trends, drivers, influence factors in global and regions.

6. To analyze Functional Genomics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Genomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Functional Genomics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Genomics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Functional Genomics industry.

Chapter 3: Detailed analysis of Functional Genomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Functional Genomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Functional Genomics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Functional Genomics Industry Trends Table 2. Functional Genomics Industry Drivers Table 3. Functional Genomics Industry Opportunities and Challenges Table 4. Functional Genomics Industry Restraints Table 5. Global Functional Genomics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Functional Genomics Revenue Share by Company (2021-2026) Table 7. Global Functional Genomics Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Functional Genomics Key Company Manufacturing Base & Headquarters Table 9. Global Functional Genomics Company, Product Type & Application Table 10. Global Functional Genomics Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Functional Genomics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Kits & Assays Table 15. Significant Companies of Instruments Table 16. Significant Companies of Assays Table 17. Global Functional Genomics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Functional Genomics Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Functional Genomics Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Functional Genomics Sales Value Share by Type (2021-2026) Table 21. Global Functional Genomics Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Transcriptomics Table 23. Significant Companies of Epigenomics Table 24. Significant Companies of Proteomics Table 25. Significant Companies of Metabolomics Table 26. Global Functional Genomics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Functional Genomics Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Functional Genomics Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Functional Genomics Sales Value Share by Application (2021-2026) Table 30. Global Functional Genomics Sales Value Share by Application (2027-2032) Table 31. Global Functional Genomics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Functional Genomics Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Functional Genomics Sales Value Share by Region (2021-2026) Table 34. Global Functional Genomics Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Functional Genomics Sales Value Share by Region (2027-2032) Table 36. Global Functional Genomics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Functional Genomics Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Functional Genomics Sales Value Market Share by Country (2021-2026) Table 39. Global Functional Genomics Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Functional Genomics Sales Value Market Share by Country (2027-2032) Table 41. Agilent Technologies, Inc. Company Information Table 42. Agilent Technologies, Inc. Business Overview Table 43. Agilent Technologies, Inc. Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Agilent Technologies, Inc. Functional Genomics Product Portfolio Table 45. Agilent Technologies, Inc. Recent Development Table 46. Becton, Dickinson and Company (BD) Company Information Table 47. Becton, Dickinson and Company (BD) Business Overview Table 48. Becton, Dickinson and Company (BD) Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Becton, Dickinson and Company (BD) Functional Genomics Product Portfolio Table 50. Becton, Dickinson and Company (BD) Recent Development Table 51. Bio-Rad Laboratories, Inc. Company Information Table 52. Bio-Rad Laboratories, Inc. Business Overview Table 53. Bio-Rad Laboratories, Inc. Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Bio-Rad Laboratories, Inc. Functional Genomics Product Portfolio Table 55. Bio-Rad Laboratories, Inc. Recent Development Table 56. (Integrated DNA Technologies, Inc.) Company Information Table 57. (Integrated DNA Technologies, Inc.) Business Overview Table 58. (Integrated DNA Technologies, Inc.) Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. (Integrated DNA Technologies, Inc.) Functional Genomics Product Portfolio Table 60. (Integrated DNA Technologies, Inc.) Recent Development Table 61. Exact Sciences Corporation Company Information Table 62. Exact Sciences Corporation Business Overview Table 63. Exact Sciences Corporation Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Exact Sciences Corporation Functional Genomics Product Portfolio Table 65. Exact Sciences Corporation Recent Development Table 66. Hoffmann-La Roche Ltd Company Information Table 67. Hoffmann-La Roche Ltd Business Overview Table 68. Hoffmann-La Roche Ltd Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Hoffmann-La Roche Ltd Functional Genomics Product Portfolio Table 70. Hoffmann-La Roche Ltd Recent Development Table 71. Illumina, Inc. Company Information Table 72. Illumina, Inc. Business Overview Table 73. Illumina, Inc. Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Illumina, Inc. Functional Genomics Product Portfolio Table 75. Illumina, Inc. Recent Development Table 76. Merck KGaA Company Information Table 77. Merck KGaA Business Overview Table 78. Merck KGaA Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck KGaA Functional Genomics Product Portfolio Table 80. Merck KGaA Recent Development Table 81. MRM Proteomics Company Information Table 82. MRM Proteomics Business Overview Table 83. MRM Proteomics Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. MRM Proteomics Functional Genomics Product Portfolio Table 85. MRM Proteomics Recent Development Table 86. Pacific Biosciences of California, Inc. Company Information Table 87. Pacific Biosciences of California, Inc. Business Overview Table 88. Pacific Biosciences of California, Inc. Functional Genomics Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Pacific Biosciences of California, Inc. Functional Genomics Product Portfolio Table 90. Pacific Biosciences of California, Inc. Recent Development Table 91. Promega Corporation Company Information Table 92. Promega Corporation Business Overview Table 93. Promega Corporation Functional Genomics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Promega Corporation Functional Genomics Product Portfolio Table 95. Promega Corporation Recent Development Table 96. QIAGEN Company Information Table 97. QIAGEN Business Overview Table 98. QIAGEN Functional Genomics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. QIAGEN Functional Genomics Product Portfolio Table 100. QIAGEN Recent Development Table 101. Thermo Fisher Scientific Inc. Company Information Table 102. Thermo Fisher Scientific Inc. Business Overview Table 103. Thermo Fisher Scientific Inc. Functional Genomics Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Thermo Fisher Scientific Inc. Functional Genomics Product Portfolio Table 105. Thermo Fisher Scientific Inc. Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Functional Genomics Product Image Figure 2. Global Functional Genomics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Functional Genomics Market Size (2021-2032) & (US$ Million) Figure 4. Global Functional Genomics Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Kits & Assays Image Figure 8. Instruments Image Figure 9. Assays Image Figure 10. Global Functional Genomics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Functional Genomics Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Functional Genomics Sales Value Share by Type (2021-2032) Figure 13. Transcriptomics Image Figure 14. Epigenomics Image Figure 15. Proteomics Image Figure 16. Metabolomics Image Figure 17. Global Functional Genomics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Functional Genomics Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Functional Genomics Sales Value Share by Application (2021-2032) Figure 20. Global Functional Genomics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Functional Genomics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Functional Genomics Sales Value (2021-2032) & (US$ Million) Figure 23. North America Functional Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Functional Genomics Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Functional Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Functional Genomics Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Functional Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Functional Genomics Sales Value (2021-2032) & (US$ Million) Figure 29. South America Functional Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Functional Genomics Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Functional Genomics Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Functional Genomics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Functional Genomics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Functional Genomics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Kits & Assays
  • Instruments
  • Assays
Applications
  • Transcriptomics
  • Epigenomics
  • Proteomics
  • Metabolomics
Companies covered
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories, Inc.
  • (Integrated DNA Technologies, Inc.)
  • Exact Sciences Corporation
  • Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • MRM Proteomics
  • Pacific Biosciences of California, Inc.
  • Promega Corporation
  • QIAGEN
  • Thermo Fisher Scientific Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Functional Genomics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Functional Genomics Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Functional Genomics Market Dynamics
  1. 2.1 Functional Genomics Industry Trends
  2. 2.2 Functional Genomics Industry Drivers
  3. 2.3 Functional Genomics Industry Opportunities and Challenges
  4. 2.4 Functional Genomics Industry Restraints
3 Functional Genomics Market by Company
  1. 3.1 Global Functional Genomics Company Revenue Ranking in 2025
  2. 3.2 Global Functional Genomics Revenue by Company (2021-2026)
  3. 3.3 Global Functional Genomics Company Ranking (2024-2026)
  4. 3.4 Global Functional Genomics Company Manufacturing Base and Headquarters
  5. 3.5 Global Functional Genomics Company Product Type and Application
  6. 3.6 Global Functional Genomics Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Functional Genomics Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Functional Genomics Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Functional Genomics Market by Type
  1. 4.1 Functional Genomics Type Introduction
  2. 4.1.1 Kits & Assays
  3. 4.1.2 Instruments
  4. 4.1.3 Assays
  5. 4.2 Global Functional Genomics Sales Value by Type
  6. 4.2.1 Global Functional Genomics Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Functional Genomics Sales Value by Type (2021-2032)
  8. 4.2.3 Global Functional Genomics Sales Value Share by Type (2021-2032)
5 Functional Genomics Market by Application
  1. 5.1 Functional Genomics Application Introduction
  2. 5.1.1 Transcriptomics
  3. 5.1.2 Epigenomics
  4. 5.1.3 Proteomics
  5. 5.1.4 Metabolomics
  6. 5.2 Global Functional Genomics Sales Value by Application
  7. 5.2.1 Global Functional Genomics Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Functional Genomics Sales Value by Application (2021-2032)
  9. 5.2.3 Global Functional Genomics Sales Value Share by Application (2021-2032)
6 Functional Genomics Regional Value Analysis
  1. 6.1 Global Functional Genomics Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Functional Genomics Sales Value by Region (2021-2032)
  3. 6.2.1 Global Functional Genomics Sales Value by Region: 2021-2026
  4. 6.2.2 Global Functional Genomics Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Functional Genomics Sales Value (2021-2032)
  7. 6.3.2 North America Functional Genomics Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Functional Genomics Sales Value (2021-2032)
  10. 6.4.2 Europe Functional Genomics Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Functional Genomics Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Functional Genomics Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Functional Genomics Sales Value (2021-2032)
  16. 6.6.2 South America Functional Genomics Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Functional Genomics Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Functional Genomics Sales Value Share by Country, 2025 VS 2032
7 Functional Genomics Country-level Value Analysis
  1. 7.1 Global Functional Genomics Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Functional Genomics Sales Value by Country (2021-2032)
  3. 7.2.1 Global Functional Genomics Sales Value by Country (2021-2026)
  4. 7.2.2 Global Functional Genomics Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Functional Genomics Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Functional Genomics Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Functional Genomics Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Functional Genomics Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Functional Genomics Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Functional Genomics Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Functional Genomics Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Functional Genomics Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Functional Genomics Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Functional Genomics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Functional Genomics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Functional Genomics Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Functional Genomics Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Functional Genomics Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Functional Genomics Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Functional Genomics Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Functional Genomics Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Functional Genomics Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Functional Genomics Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Functional Genomics Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Functional Genomics Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Functional Genomics Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Functional Genomics Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Functional Genomics Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Functional Genomics Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Functional Genomics Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Functional Genomics Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Functional Genomics Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Functional Genomics Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Functional Genomics Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Functional Genomics Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Functional Genomics Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Functional Genomics Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Functional Genomics Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Functional Genomics Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Functional Genomics Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Functional Genomics Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Functional Genomics Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Functional Genomics Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Functional Genomics Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Functional Genomics Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Functional Genomics Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Functional Genomics Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Functional Genomics Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Functional Genomics Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Functional Genomics Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Functional Genomics Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Functional Genomics Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Functional Genomics Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Functional Genomics Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Functional Genomics Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Functional Genomics Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Functional Genomics Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Functional Genomics Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Functional Genomics Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Functional Genomics Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Functional Genomics Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Functional Genomics Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Functional Genomics Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Functional Genomics Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Functional Genomics Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Functional Genomics Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Functional Genomics Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Functional Genomics Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Functional Genomics Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Functional Genomics Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Functional Genomics Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Functional Genomics Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Functional Genomics Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Functional Genomics Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Functional Genomics Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Functional Genomics Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Functional Genomics Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Functional Genomics Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Functional Genomics Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Functional Genomics Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Functional Genomics Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Functional Genomics Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Functional Genomics Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Functional Genomics Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Functional Genomics Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Functional Genomics Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Functional Genomics Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Functional Genomics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Agilent Technologies, Inc.
  2. 8.1.1 Agilent Technologies, Inc. Company Information
  3. 8.1.2 Agilent Technologies, Inc. Business Overview
  4. 8.1.3 Agilent Technologies, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Agilent Technologies, Inc. Functional Genomics Product Portfolio
  6. 8.1.5 Agilent Technologies, Inc. Recent Developments
  7. 8.2 Becton, Dickinson and Company (BD)
  8. 8.2.1 Becton, Dickinson and Company (BD) Company Information
  9. 8.2.2 Becton, Dickinson and Company (BD) Business Overview
  10. 8.2.3 Becton, Dickinson and Company (BD) Functional Genomics Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Becton, Dickinson and Company (BD) Functional Genomics Product Portfolio
  12. 8.2.5 Becton, Dickinson and Company (BD) Recent Developments
  13. 8.3 Bio-Rad Laboratories, Inc.
  14. 8.3.1 Bio-Rad Laboratories, Inc. Company Information
  15. 8.3.2 Bio-Rad Laboratories, Inc. Business Overview
  16. 8.3.3 Bio-Rad Laboratories, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bio-Rad Laboratories, Inc. Functional Genomics Product Portfolio
  18. 8.3.5 Bio-Rad Laboratories, Inc. Recent Developments
  19. 8.4 (Integrated DNA Technologies, Inc.)
  20. 8.4.1 (Integrated DNA Technologies, Inc.) Company Information
  21. 8.4.2 (Integrated DNA Technologies, Inc.) Business Overview
  22. 8.4.3 (Integrated DNA Technologies, Inc.) Functional Genomics Revenue and Gross Margin (2021-2026)
  23. 8.4.4 (Integrated DNA Technologies, Inc.) Functional Genomics Product Portfolio
  24. 8.4.5 (Integrated DNA Technologies, Inc.) Recent Developments
  25. 8.5 Exact Sciences Corporation
  26. 8.5.1 Exact Sciences Corporation Company Information
  27. 8.5.2 Exact Sciences Corporation Business Overview
  28. 8.5.3 Exact Sciences Corporation Functional Genomics Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Exact Sciences Corporation Functional Genomics Product Portfolio
  30. 8.5.5 Exact Sciences Corporation Recent Developments
  31. 8.6 Hoffmann-La Roche Ltd
  32. 8.6.1 Hoffmann-La Roche Ltd Company Information
  33. 8.6.2 Hoffmann-La Roche Ltd Business Overview
  34. 8.6.3 Hoffmann-La Roche Ltd Functional Genomics Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hoffmann-La Roche Ltd Functional Genomics Product Portfolio
  36. 8.6.5 Hoffmann-La Roche Ltd Recent Developments
  37. 8.7 Illumina, Inc.
  38. 8.7.1 Illumina, Inc. Company Information
  39. 8.7.2 Illumina, Inc. Business Overview
  40. 8.7.3 Illumina, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Illumina, Inc. Functional Genomics Product Portfolio
  42. 8.7.5 Illumina, Inc. Recent Developments
  43. 8.8 Merck KGaA
  44. 8.8.1 Merck KGaA Company Information
  45. 8.8.2 Merck KGaA Business Overview
  46. 8.8.3 Merck KGaA Functional Genomics Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck KGaA Functional Genomics Product Portfolio
  48. 8.8.5 Merck KGaA Recent Developments
  49. 8.9 MRM Proteomics
  50. 8.9.1 MRM Proteomics Company Information
  51. 8.9.2 MRM Proteomics Business Overview
  52. 8.9.3 MRM Proteomics Functional Genomics Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MRM Proteomics Functional Genomics Product Portfolio
  54. 8.9.5 MRM Proteomics Recent Developments
  55. 8.10 Pacific Biosciences of California, Inc.
  56. 8.10.1 Pacific Biosciences of California, Inc. Company Information
  57. 8.10.2 Pacific Biosciences of California, Inc. Business Overview
  58. 8.10.3 Pacific Biosciences of California, Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pacific Biosciences of California, Inc. Functional Genomics Product Portfolio
  60. 8.10.5 Pacific Biosciences of California, Inc. Recent Developments
  61. 8.11 Promega Corporation
  62. 8.11.1 Promega Corporation Company Information
  63. 8.11.2 Promega Corporation Business Overview
  64. 8.11.3 Promega Corporation Functional Genomics Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Promega Corporation Functional Genomics Product Portfolio
  66. 8.11.5 Promega Corporation Recent Developments
  67. 8.12 QIAGEN
  68. 8.12.1 QIAGEN Company Information
  69. 8.12.2 QIAGEN Business Overview
  70. 8.12.3 QIAGEN Functional Genomics Revenue and Gross Margin (2021-2026)
  71. 8.12.4 QIAGEN Functional Genomics Product Portfolio
  72. 8.12.5 QIAGEN Recent Developments
  73. 8.13 Thermo Fisher Scientific Inc.
  74. 8.13.1 Thermo Fisher Scientific Inc. Company Information
  75. 8.13.2 Thermo Fisher Scientific Inc. Business Overview
  76. 8.13.3 Thermo Fisher Scientific Inc. Functional Genomics Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Thermo Fisher Scientific Inc. Functional Genomics Product Portfolio
  78. 8.13.5 Thermo Fisher Scientific Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst